The Vision

TumorGen MDx is dedicated to rapidly enhancing cancer therapy. Our primary goal is to exponentially improve treatment options for patients by developing revolutionary microfluidic systems able to capture and viable human Cancer Stem Cells (CSCs). Once isolated, using next generation DNA analysis on CSCs will identify the critical breaks (mutations) within the DNA, that ultimately result in the uncontrolled cell growth emblematic of cancer. Illuminating the DNA mutations within CSCs will allow medical professionals to identify the essential ‘Targeted Therapies’ required to stop cancer metastases.